UpToDate subscription cost and pricing, and why no price is published

Because the money is in the institutional contracts, and those are negotiated one organization at a time. A published rate card would set a public anchor for every single one of those negotiations, and it would do it in the buyer's favor. So the store asks who you are first and quotes second.

The clearest evidence for that reading sits inside the same company. Wolters Kluwer publishes $29.99 a month for UpToDate Lexidrug on the US App Store, plainly, where anyone can read it. It publishes nothing at all for UpToDate. Same vendor, same month, opposite policy. The difference is not product quality or complexity. It is that Lexidrug is bought by a clinician with a credit card and UpToDate is bought by a procurement department.

That pattern holds across this market. Everything sold to an individual carries a price you can read before you commit. Everything sold to an institution carries a phone number. Micromedex, sold almost entirely to hospital pharmacies, publishes nothing either.

The store says it directly: for medical groups and organizations with twenty or more users, you are pointed to enterprise solutions or to sales. That single sentence is the most useful thing published about UpToDate pricing, because it tells you which process you are about to enter.

Under twenty seats you can generally handle it yourself. The store supports adding group members and renewing them, so a five-physician practice can buy without ever speaking to anybody. At twenty and above you are in a procurement cycle: a quote, a contract, a renewal date, and a rate that depends on how well the negotiation goes. Two practices of the same size can pay very different amounts, and neither will ever know.

There is a third door most people never notice. UpToDate for Healthcare Businesses is a separate track for organizations that do not provide patient care, such as payers, life sciences companies and consultancies. If that describes you, the clinical contract is not the one you want. We cover the mechanics of both in the institutional license and enterprise pricing guide.

UpToDate is a graded clinical reference. Topic reviews written and edited by named clinicians, updated continuously, with recommendation grades attached. Its job is to answer "how should this patient be managed", and it is very good at that job. The app also carries over 200 clinical calculators, which is a genuine part of the value and rarely mentioned in pricing discussions.

What surprises buyers is where the drug information comes from. UpToDate's drug monographs are Lexidrug content, from the same vendor. If the reason you are considering a subscription is drug lookups, interactions and dosing rather than management questions, you may be paying for a disease reference in order to reach a drug database you could license directly for a published $29.99 a month. That is worth ten minutes of thought before renewal, and it is the whole argument of our UpToDate vs Lexicomp comparison.

One more feature is worth knowing about because it is gated by tier rather than sold separately. Expert AI, the vendor's assistant layer, is limited to personal trainee subscriptions, Pro Plus and select enterprise accounts. If that capability is the reason you are upgrading, confirm your specific tier includes it rather than assuming a paid subscription is enough.